CPhI Biopharma News

Jan 19, 2018
By BioPharm International Editors
Lonza Pharma & Biotech's's Modular Automated Sampling Technology (MAST) platform, which allows for the collection of up to 10 sterile sample sources for automated analysis in multiple analytical devices, won the CPhI Pharma Award 2017 for Excellence in Pharma: Bioprocessing.
Jan 19, 2018
By BioPharm International Editors
1CryoBio’s Flexiquot technology allows for the deep-freeze storage and handling of multiple aliquots in a single tube, winning it the CPhI Pharma Award 2017 for Excellence in Pharma: Analysis, Testing, and Quality Control.
Jan 08, 2018
By BioPharm International Editors
AptarGroup’s Landfill Free Certification program addresses the issue of waste production from pharmaceutical manufacturing processes by prompting its facilities to reduce and reuse operation waste.
Nov 16, 2017
By BioPharm International Editors
India was ranked by international pharmaceutical companies as the third most competitive nation globally.
Nov 16, 2017
By BioPharm International Editors
Germany tops quality ranking in the inaugural CPhI Global Pharma Index.
Oct 26, 2017
By BioPharm International Editors
The new BioLive event, which will be a global hub for biopharmaceutical manufacturing, will launch alongside CPhI Worldwide 2018 in Madrid.
Oct 25, 2017
By BioPharm International Editors
Russian biotechnology company Biocad plans to enter the European market with oncological and autoimmune medicines.
Oct 24, 2017
By BioPharm International Editors
How soon could the pharmaceutical industry see a widespread adoption of emerging technologies that are poised to shape its future?
Oct 24, 2017
By BioPharm International Editors
Girish Malhorta, CPhI expert and president of EPCOT International, discussed world revenues for pharmaceuticals and how companies may improve cost and availability of drugs in CPhI’s 2017 Annual Report.
Oct 17, 2017
By BioPharm International Editors
DSM Sinochem Pharmaceuticals has filed a lawsuit against CSPC Pharmaceutical Group, Inner Mongolia Changsheng Pharmaceutical Company, and CSPC Zhangnuo Pharmaceutical (Shijiazhuang) for infringement of its amoxicillin patent.
native1_300x100
lorem ipsum